Sinotherapeutics Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SINOTHERAPEUTICS INC, and what generic and branded alternatives to SINOTHERAPEUTICS INC drugs are available?
SINOTHERAPEUTICS INC has five approved drugs.
Summary for Sinotherapeutics Inc
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Sinotherapeutics Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sinotherapeutics Inc | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 212970-001 | Apr 9, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sinotherapeutics Inc | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210339-002 | Jan 4, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sinotherapeutics Inc | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208652-001 | Aug 21, 2017 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
